Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Considering Alternatives To Abbreviated Inspections As QSIT Gears Up

This article was originally published in The Gray Sheet

Executive Summary

Quality systems inspections of device manufacturers between Oct. 1, 1999 and Jan. 1, 2000 will employ either traditional or Quality Systems Inspection Technique (QSIT) methods, depending on inspector training, FDA officials report.

You may also be interested in...



MDMA Identifies Top FDA, HCFA Priorities In 2001 Public Policy Agenda

The Medical Device Manufacturers Association's 2001 public policy agenda spotlights the debate over the claims substantiation guidance, which is expected to be released this year.

MDMA Identifies Top FDA, HCFA Priorities In 2001 Public Policy Agenda

The Medical Device Manufacturers Association's 2001 public policy agenda spotlights the debate over the claims substantiation guidance, which is expected to be released this year.

CDRH QSIT Team Considers Third-Party Audit Option To Level 1 Inspections

Firms with a good compliance history may be eligible to submit third-party auditing certifications in lieu of biennial FDA inspections, according to a proposal being drafted for consideration by the Center for Devices and Radiological Health's quality systems inspection technique (QSIT) reengineering team.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT012382

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel